Improve definition of titanium tandems in MR-guided high dose rate brachytherapy for cervical cancer using proton density weighted MRI
© Hu et al.; licensee BioMed Central Ltd. 2013
Received: 28 August 2012
Accepted: 13 January 2013
Published: 17 January 2013
For cervical cancer patients treated with MR-guided high dose rate brachytherapy, the accuracy of radiation delivery depends on accurate localization of both tumors and the applicator, e.g. tandem and ovoid. Standard T2-weighted (T2W) MRI has good tumor-tissue contrast. However, it suffers from poor uterus-tandem contrast, which makes the tandem delineation very challenging. In this study, we evaluated the possibility of using proton density weighted (PDW) MRI to improve the definition of titanium tandems.
Both T2W and PDW MRI images were obtained from each cervical cancer patient. Imaging parameters were kept the same between the T2W and PDW sequences for each patient except the echo time (90 ms for T2W and 5.5 ms for PDW) and the slice thickness (0.5 cm for T2W and 0.25 cm for PDW). Uterus-tandem contrast was calculated by the equation C = (Su-St)/Su, where Su and St represented the average signal in the uterus and the tandem, respectively. The diameter of the tandem was measured 1.5 cm away from the tip of the tandem. The tandem was segmented by the histogram thresholding technique.
PDW MRI could significantly improve the uterus-tandem contrast compared to T2W MRI (0.42±0.24 for T2W MRI, 0.77±0.14 for PDW MRI, p=0.0002). The average difference between the measured and physical diameters of the tandem was reduced from 0.20±0.15 cm by using T2W MRI to 0.10±0.11 cm by using PDW MRI (p=0.0003). The tandem segmented from the PDW image looked more uniform and complete compared to that from the T2W image.
Compared to the standard T2W MRI, PDW MRI has better uterus-tandem contrast. The information provided by PDW MRI is complementary to those provided by T2W MRI. Therefore, we recommend adding PDW MRI to the simulation protocol to assist tandem delineation process for cervical cancer patients.
KeywordsCervical cancer MRI HDR Brachytherapy T2 weighting Proton density weighting
High dose rate
Magnetic resonance imaging
Diffusion weighted imaging
The Groupe Européen de Curiethérapie - the European Society for Therapeutic Radiology and Oncology
Proton density weighted
Signal to noise ratio
Turbo spin echo
Field of view
Region of interest.
Cervical cancer ranks the third in the United States based on the average number of life years lost due to cancer . It continues to be a significant problem in the United States and worldwide. In our clinic, cervical cancer patients are treated with daily external beam radiation therapy and weekly high dose rate (HDR) brachytherapy [2–4]. In HDR brachytherapy, radiation is delivered through a “tandem and ovoid” applicator. Knowledge of precise locations of both the tumor and the applicator relative to internal anatomy is essential to ensure radiation delivery accuracy, which may turn into improved local control and reduced morbidity.
Imaging modalities used for treatment planning for cervical cancer patients include computed tomography (CT) [5, 6] and magnetic resonance imaging (MRI) [7–12]. Currently, CT is considered as the standard imaging modality for radiotherapy treatment planning for cervical cancer. It is fast and has a good spatial resolution. However, CT has poor soft tissue contrast, which makes it very challenging to delineate the tumor from surrounding tissues. MRI has great soft tissue contrast. It offers a variety of sequences such as T2 weighted (T2W) MRI and diffusion weighted imaging (DWI) to enhance the contrast between tumors and surrounding tissues. With better tumor-tissue contrast, it is possible to customize the treatment for each fraction based on the size and location of the cervical tumor. In addition, MRI does not involve any ionizing radiation and won’t add radiation dose to patients. Those advantages make MRI highly desirable in radiation oncology, especially in pelvic area such as cervical cancer.
The “tandem and ovoid” applicator used to treat cervical cancer is made of titanium. It is light, strong and compatible with the MRI imaging modality. However, it does introduce artifact to MRI images. Titanium is paramagnetic whereas soft tissues are in general slightly diamagnetic. When titanium tandems are placed in cervical cancer patients treated with HDR brachytherapy, the susceptibility difference between the titanium tandems and surrounding soft tissues can result in local magnetic field gradients along the interface, causing signal loss and geometric distortion around titanium tandems. Since titanium doesn’t contain hydrogen atoms, tandems are dark in MRI images. In standard T2W MRI images, the uterus signal is typically very low due to the use of long echo time (TE). As a result, the contrast between the uterus and the tandem is pretty low, making the tandem delineation challenging. Using titanium applicators in MR-guided brachytherapy has been investigated in several studies [13–16]. Haack et al. reported that albeit very challenging, it was possible to assess titanium applicator geometry on T1 weighted (T1W) and T2W MRI images . Wills et al. showed the feasibility of reconstructing titanium applicator using images from 0.35T open MRI scanner .
Reducing metal artifacts has been discussed substantially in MRI field for a long time and several sequences have been developed to address this issue [17–20]. However, those techniques remain mostly in research studies. They have not been widely adopted in clinical applications, primarily because 1) they are not very robust, and 2) most existing clinical MRI scanners don’t have the capability to incorporate work-in-progress sequences. Therefore, establishing new methods to reduce metal artifacts by exploiting the available product sequences and optimizing imaging parameters can be more beneficial to clinical work.
For MR-guided HDR brachytherapy for cervical cancer, the most commonly used sequence is T2W MRI because it can provide good tumor-tissue contrast . However, using long TE in T2W MRI not only makes it very susceptible to susceptibility gradients caused by metal implants, but also significantly reduces the uterus signal and thus the contrast between the uterus and the titanium tandem. As a result, tandem delineation becomes a challenging and time consuming process. GEC-ESTRO (The Groupe Européen de Curiethérapie - the European Society for Therapeutic Radiology and Oncology) recommended that in some situation it can be can an option to acquire CT images or additional MRI image set to assist tandem delineation and streamline the whole process. Since CT scans involves unwanted radiation, acquiring another MRI image set is more preferable. Among available MRI sequences, T1W MRI is one option. Using T1W MRI to assist tandem delineation has been discussed previously in several studies [14, 16, 22]. In this study, we focused our effort on another commonly available MRI sequence - proton density weighted (PDW) MRI, which might be used to assist tandem delineation but hadn’t received enough discussion yet.
Compared to T2W MRI, PDW MRI uses a very short TE and a very long repetition time (TR)  which makes it highly SNR (signal to noise ratio) efficient and also less sensitive to susceptibility effect. High SNR efficiency can enhance the contrast between the uterus and the titanium tandem, making tandem delineation easier. In addition, it is possible to trade SNR for thinner slice, which helps mitigate the signal loss around titanium tandems. PDW MRI is available on almost all commercial MRI scanners, just like T2W MRI. Therefore, improved uterus-tandem contrast and reduced tandem delineation effort can be achieved on any existing MRI scanner.
To show the effectiveness of using PDW MRI in assisting the delineation of the “tandem and ovoid” applicator, we retrospectively reviewed MRI images from cervical cancer patients who were treated with MR-guided HDR brachytherapy in our clinic and had both T2W and PDW images acquired. This study was approved by the Human Research Protection Office and the Protocol Review and Monitoring Committee of the Washington University School of Medicine. We retrospectively reviewed MRI images from ten patients treated from 11/2010 to 01/2011. The average patient age was 52.8±10.4 years.
After the placement of the applicator, cervical cancer patients were taken to the MRI suite for simulation. All MRI images were acquired on a 1.5T MRI scanner (Intera, Philips Medical Systems, Best, Netherlands). The body coil was used to transmit the Radiofrequency excitation pulse and a 4-channel pelvic coil was used to receive the signal. The imaging protocol started with a 3-plane localizer, followed by a reference scan to determine the coil sensitivity. After that, fat-saturated T2W images in axial plane were acquired. This image set was used to guide the subsequent para-sagittal images so that the tandem was parallel to the acquired para-sagittal plane and could be seen clearly as a whole in para-sagittal slices. T2W and PDW images in the para-sagittal plane were acquired subsequently. The Turbo spin echo (TSE) imaging technique was used in both sequences. Imaging parameters for T2W MRI are listed below. Slice thickness was 5 mm, gap between adjacent slices was 0 mm, in-plane resolution was 1 mm×1 mm and TE was 90 ms. The field of view (FOV) and the number of slices were determined according to patient’s anatomy. In PDW MRI, in-plane resolution was 1 mm×1 mm and TE was 5.5 ms. Since PDW MRI has high SNR efficiency, we were able to reduce slice thickness to 2.5 mm to decrease sequence’s sensitivity to susceptibility effect caused by metal implants but still maintain a good SNR for treatment planning. The number of slices and the in-plane FOV were kept the same as those used in T2W MRI. In slice-selected direction, PDW MRI had only half of the coverage compared to that provided by T2W MRI. The reduced coverage of PDW MRI in slice-select direction was justified as the main purpose of PDW MRI was to assist tandem delineation. The range of TR for both sequences was set between 3000 ms and 6000 ms, with the exact value determined by the scanner after optimization. After all scans were finished, images were sent to BrachyVision (Varian Medical Systems) for treatment planning and to the corresponding author’s workstation after de-identification for further image analysis.
During the entire treatment, each cervical cancer patient received 6 HDR brachytherapy procedures, or fractions. Since the improvement in uterus-tandem contrast is similar in all fractions, only images from the first fraction were used in this study. The comparison of T2W and PDW MRI were performed in both qualitative and quantitative methods.
Qualitatively, we compared T2W and PDW MRI images to determine which image sets had a better definition of the tandem. Signal profiles along a line which was perpendicular to the titanium tandem were obtained for both image sets. In addition, we segmented the tandem from surrounding tissues based on the histogram thresholding approach  and compared the segmented images obtained from T2W and PDW MRI images. In the histogram thresholding approach, one slice containing the majority portion of the tandem was selected from each image sets. A small region of interest (ROI) was placed around the tip of the tandem. Only two structures were included in the ROI: the tandem and the uterus. Histograms of the signal in the selected ROI were plotted for both image sets. Peaks in histograms corresponded to either the uterus or the tandem. Histograms were examined to see if peaks corresponding to the tandem and the uterus could be easily separated. A threshold was determined based on each histogram and was used to segment the corresponding MRI image. Voxels with signal intensity above the threshold (presumably the uterus) were set to 0. The rest of voxels (presumably the tandem) were set to 1. Structures other than the uterus and tandem are of little concerns in this segmentation process. The segmented images were visually inspected for the effectiveness of the segmentation.
Quantitatively, we compared the measured diameter of the tandem. The measurement was performed by an experienced medical physicist. On T2W images, the diameter of the tandem varies with the distance from the tip of the tandem. In addition, adjusting the windowing level also changes the measured diameter. To standardize the procedure of the measurement and reduce the corresponding bias as much as possible, the following two steps were performed during the measurement. First, the window level was determined based on the plastic ovoid because it has minimal geometric distortion in spin echo sequences. For each image, the window level was set so that the diameter of the ovoid was within 0.1 cm of the actual diameter. Second, the diameter of the tandem was measured at 1.5 cm from the tip of the tandem. The tip of the tandem was determined based on the PDW MRI image due to its better image quality. This measurement location was mapped to the co-registered T2W MRI image to ensure that the diameter was measured at the same location for both T2W and PDW images. The measured diameters of the tandem from MRI images were compared to the physical diameter, which was 0.345 cm determined by the caliper.
The contrast between the uterus and the tandem was also quantitatively determined for each patient and each image set. Again, the measurement was performed at the location which was 1.5 cm from the tip of the tandem. At this location, we drew a line which was perpendicular to the tandem. Along this line, two ROIs were placed. One was at the middle of the tandem and the other was 1.0 cm from the tandem in the uterus area. The size of the ROI within the uterus was 3 mm×3 mm, whereas the size of the ROI within the tandem was 1.5 mm×1.5 mm due to the small diameter of the tandem. The contrast can be determined by equation C = (Su − St)/Su, where Su is the average signal in the uterus and St is the average signal in the tandem.
Measured uterus, tandem signal as well as the uterus-tandem contrast
Paired student t-test
Measured tandem diameters
Diameter of ovoid (cm)
Measured diameter (cm)
Difference from physical diameter (cm)
Paired student t-test
The feasibility of using PDW MRI to assist tandem delineation for cervical cancer patients treated with HDR brachytherapy was proved in this work. It was shown that PDW MRI had a better uterus-tandem contrast compared to T2W MRI. Qualitatively, the tandem had a better and more uniform shape on PDW MRI. Quantitatively, the difference between measured and physical diameters of the tandem was significantly reduced by using PDW MRI, confirming PDW MRI had reduced artifacts.
Although one of the standard methods to reduce geometric distortion and signal dropout is to increase the bandwidth and/or matrix size, it may not be a practical solution to improve image quality of T2W MRI and reduce effort in tandem delineation. In T2W MRI, the uterus signal is typically very low because of the use of long TE. The uterus-tandem contrast is barely enough for the delineation purpose. Increasing the bandwidth and/or matrix size, however, will significantly reduce the image SNR and thus the uterus-tandem contrast, making tandem delineation extremely difficult, if not impossible at all. PDW MRI uses a very short (5.5 ms vs. 90 ms). Therefore, the uterus signal is much higher in PDW MRI compared to T2W MRI, which not only increases the uterus-tandem contrast, but also allows us to use thinner slices to further reduce the geometric distortion and signal dropout around the titanium tandem. T1W MRI utilizes a TE which is comparable to PDW MRI. When T1W and PDW images are acquired using the same TE, bandwidth and spatial resolution, the two image datasets should exhibit similar amount of metal artifacts. On the other hand, T1W MRI utilizes a relatively shorter TR compared to PDW MRI, which makes it less SNR efficient. The long TR used in PDW MRI allows the magnetization to be fully relaxed before the next excitation. Therefore, more magnetization will be available at the beginning of each RF excitation, resulting in higher signal (or SNR) in PDW MRI. The SNR advantage of PDW MRI may be traded off for better spatial resolution, which will further reduce metal artifacts.
Image fusion between the T2W and PDW images was accomplished by using the coordinates stored in the DICOM header. This was warranted in this study because 1) the tabletop supporting patients did not move between the T2W and PDW MRI scans, all MRI images were acquired by changing the imaging hardware such as gradients; and 2) patients were still under medication for pain control which made them sleepy and less likely to move. None of the 10 patients included in this study showed significant movement between T2W and PDW MRI. If in future we do observe significant movement between scans, we can implement sophisticated fusion techniques based on patient’s anatomy to ensure the accuracy of the quantitative analysis.
The measured diameters from MRI images had a relatively large variance among patients. The largest measurement was 0.79 cm in one of the T2W images whereas the smallest measurement was 0.29 cm in one of the PDW images. The standard deviations in diameter measurement were 0.15 cm and 0.11 cm for T2W and PDW images, respectively. After examining Table 1, we noticed that there was a good correlation between the measured diameters from T2W images and PDW images. Specifically, if the measured diameter from the T2W image was large, the corresponding measured tandem diameter from the PDW image was also large and vice versa. In addition, we found that the measured diameter of the tandem correlated well with the curvature of the tandem. Patients using a tandem with bigger curvature tended to have a larger measured diameter. If patients were grouped by the curvature of the tandem, 3 patients had tandem curvature of 30° and 7 patients had tandem curvature of 45°. For the group with tandem curvature of 30°, the standard deviation of measured diameters reduced to 0.05 cm by using the T2W images and to 0.04 cm by using the PDW images. Similarly, for the group with tandem curvature of 45°, the standard deviation of measured diameters reduced to 0.10 cm by using the T2W images and to 0.08 cm by using the PDW images. We also noticed that some of the measured diameters were smaller than the physical diameter of the tandem. This may be explained by the relative location of the slices to the tandem. If the tandem is equally distributed into two adjacent para-sagittal slices along its axis, then each slice contains half of the tandem. Since the radius of the tandem is smaller than the slice thickness, for any voxels within the region of the tandem, it contains both tandem and the uterus. This partial volume effect may lower the contrast between the tandem and the uterus, making the measured diameter of the tandem smaller than its physical diameter. All these observations suggest that the measured diameter of the tandem is related to the curvature of the tandem, the location of slices, and the placement of the receiving coil and the applicator as well. Further investigation is needed and will be conducted in the future to fully understand the causes.
The focus of this retrospective study was to show the feasibility of using PDW MRI as an option to assist tandem delineation for cervical cancer patients treated with HDR brachytherapy. Other options to assist tandem delineation include acquiring additional x-ray images, CT images, T1W MRI or other MRI image-sets. Evaluating those options to find the best choice is a very interesting topic and of great clinical importance. However, it is out of the scope of this study. Such kind of study will be planned and performed in the future after being carefully designed to minimize the bias in the process of comparing images from different imaging modalities. Another interesting project is to compare dwell positions determined by MR images (T2W, T1W and PDW) and CT images. In our preliminary study on phantom , we found that mean differences between activated dwells on MRI vs. CT were approximately 0.1cm or less, 0.2 cm and 0.1 cm in RL (right-left), FH (foot-head), and AP (anterior-posterior) directions, respectively. Comparisons between T2W and PDW MRI showed about 0.1 cm difference in the FH direction and negligible differences in the other directions. Comparison of dwell positions using patient image datasets is currently under investigation.
In this work, it was demonstrated that PDW MRI had a better uterus-tandem contrast compared to the standard T2W MRI and therefore could be used optionally to assist tandem delineation. The good uterus-tandem contrast provided by PDW MRI is complementary to the good tumor-tissue contrast offered by T2W MRI. By combing two images sets, it is possible to achieve both good tumor delineation and good tandem delineation simultaneously for cervical cancer patients treated with HDR brachytherapy.
- Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, et al.: SEER Cancer Statistics Review, 1975–2007. MD: National Cancer Institute Bethesda; http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web site, 2010
- Nag S, Erickson B, Thomadsen E, Orton C, Demanes JD, Petereit D, Soc AB: The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000, 48:201–211.PubMedView Article
- Patel FD, Sharma SC, Negi PS, Ghoshal S, Gupta BD: Low-Dose Rate Vs High-Dose-Rate Brachytherapy in the Treatment of Carcinoma of the Uterine Cervix - a Clinical-Trial. Int J Radiat Oncol Biol Phys 1994, 28:335–341.PubMedView Article
- Hareyama M, Sakata K, Oouchi A, Nagakura H, Shido M, Someya M, Koito K: High-dose-rate versus low-dose-rate intracavitary therapy for carcinoma of the uterine cervix - a randomized trial. Cancer 2002, 94:117–124.PubMedView Article
- Aird EGA, Conway J: CT simulation for radiotherapy treatment planning. Br J Radiol 2002, 75:937–949.PubMed
- Hellebust TP, Tanderup K, Bergstrand ES, Knutsen BH, Roislien J, Olsen DR: Reconstruction of a ring applicator using CT imaging: impact of the reconstruction method and applicator orientation. Phys Med Biol 2007, 52:4893–4904.PubMedView Article
- Rasch C, Barillot I, Remeijer P, Touw A, van Herk M, Lebesque JV: Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys 1999, 43:57–66.PubMedView Article
- Li G, Citrin D, Camphausen K, Mueller B, Burman C, Mychalczak B, Miller RW, Song YL: Advances in 4D medical imaging and 4D radiation therapy. Technology in Cancer Research & Treatment 2008, 7:67–81.
- Zhu J, Ma D, Lu W, Mutic S, Low D, Grigsby P: MRI-guided Radiotherapy of Cervical Carcinoma: Applications with Diffusion MRI and MR Spectroscopy. Int J Radiat Oncol Biol Phys 2009, 75:S371-S371.View Article
- Berger D, Dimopoulos J, Potter R, Kirisits C: Direct reconstruction of the Vienna applicator on MR images. Radiother Oncol 2009, 93:347–351.PubMedView Article
- De Leeuw AA, Moerland MA, Nomden C, Tersteeg RH, Roesink JM, Jurgenliemk-Schulz IM: Applicator reconstruction and applicator shifts in 3D MR-based PDR brachytherapy of cervical cancer. Radiother Oncol 2009, 93:341–346.PubMedView Article
- Perez-Calatayud J, Kuipers F, Ballester F, Granero D, Richart J, Rodriguez S, Tormo A, Santos M: Exclusive MRI-based tandem and colpostats reconstruction in gynaecological brachytherapy treatment planning. Radiother Oncol 2009, 91:181–186.PubMedView Article
- Hellebust TP, Kirisits C, Berger D, Perez-Calatayud J, De Brabandere M, De Leeuw A, Dumas I, Hudej R, Lowe G, Wills R, Tanderup K: Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group: considerations and pitfalls in commissioning and applicator reconstruction in 3D image-based treatment planning of cervix cancer brachytherapy. Radiother Oncol 2010, 96:153–160.PubMedView Article
- Haack S, Nielsen SK, Lindegaard JC, Gelineck J, Tanderup K: Applicator reconstruction in MRI 3D image-based dose planning of brachytherapy for cervical cancer. Radiother Oncol 2009, 91:187–193.PubMedView Article
- Wills R, Lowe G, Inchley D, Anderson C, Beenstock V, Hoskin P: Applicator reconstruction for HDR cervix treatment planning using images from 0.35 T open MR scanner. Radiother Oncol 2010, 94:346–352.PubMedView Article
- Kim Y, Muruganandham M, Modrick JM, Bayouth JE: Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer. Int J Radiat Oncol Biol Phys 2011, 80:947–955.PubMedView Article
- Cho ZH, Kim DJ, Kim YK: Total inhomogeneity correction including chemical shifts and susceptibility by view angle tilting. Med Phys 1988, 15:7–11.PubMedView Article
- Kolind SH, MacKay AL, Munk PL, Xiang QS: Quantitative evaluation of metal artifact reduction techniques. J Magn Reson Imaging 2004, 20:487–495.PubMedView Article
- Butts K, Pauly JM, Gold GE: Reduction of blurring in view angle tilting MRI. Magn Reson Med 2005, 53:418–424.PubMedView Article
- Lu W, Pauly KB, Gold GE, Pauly JM, Hargreaves BA: SEMAC: Slice Encoding for Metal Artifact Correction in MRI. Magn Reson Med 2009, 62:66–76.PubMedView Article
- Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, Lowenstein J, Roll J, Thomadsen B, Varia M: Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: Report from Image-Guided Brachytherapy Working Group. Int J Radiat Oncol Biol Phys 2004, 60:1160–1172.PubMedView Article
- Tanderup K, Hellebust TP, Lang S, Granfeldt J, Potter R, Lindegaard JC, Kirisits C: Consequences of random and systematic reconstruction uncertainties in 3D image based brachytherapy in cervical cancer. Radiother Oncol 2008, 89:156–163.PubMedView Article
- Jackson EF, Ginsberg LE, Schomer DF, Leeds NE: A review of MRI pulse sequences and techniques in neuroimaging. Surg Neurol 1997, 47:185–199.PubMedView Article
- Sezgin M, Sankur B: Survey over image thresholding techniques and quantitative performance evaluation. Journal of Electronic Imaging 2004, 13:146–168.View Article
- Esthappan J, Garcia-Ramirez J, Hu Y, Grigsby PW: Transition from CT to MR Imaging of Titanium Applicators for 3D Image‐Based High Dose Rate Cervix Cancer Brachytherapy. Medical Physics 2011, 38:3428.View Article
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.